BiotechPark with Innovation- and Incubationscenter

diagram

Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.

With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.

The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.

Since 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch offers an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.

„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.

Otto Warburg House

News innovation

Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased sales in the first nine months of 2025 by 4% to €224.1 million compared to the same period last year. EBIT before special items from continuin...

more ...

T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy

Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing. TK-6302 Clinical Trial Application planned in Q4 20...

more ...

Eckert & Ziegler Gains Approval for GalliaPharm® in Japan

Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, has received marketing authorization in Japan ...

more ...

Events Campus

18.11.2025, 18:00
Von Kobalt-Kanone bis Schlaftherapie: Medizinstandort Buch in DDR-Filmdokumentationen

Filmabend mit historischem Filmmaterial

more ...

21.11.2025, 19:00
Der Jeanne Mammen Salon „ein herrlicher Schatz“

Anlässlich des 135. Geburtstags der Berliner Künstlerin lassen wir am 21. November 2025 ab 19:00 Uhr im Jeanne Mammen Saal im Torhaus des Campus Berlin-Buch die Tradition der Berliner Salonabende mit ...

more ...

16.12.2025, 15:30
Weihnachtliche Führung durch die einzigartige Sammlung historischer Mikroskope auf dem Campus Berlin-Buch

Lernen Sie die Anfänge der Berliner Mikroskop-Produktion und ihren Einfluss auf die moderne Biomedizin kennen - unter anderem auf die medizinische Forschung in Berlin-Buch!

more ...

Sponsoren der Website: